Xia Xiao
Investor at HashKey Capital
Abu Dhabi Emirate
Overview
Work Experience
Investor Relations
2024 - Current
Strategy Director
2021 - 2023
- Collaborated with the CEO, VP and other key stakeholders to develop and implement the company’s strategy, business development, and led the company’s fund raising and investor relation practice - Built and led the PCR business unit
Investment Professional
2019 - 2021
- Sourced, evaluated, and negotiated investment terms for deals across multiple sectors and stages - Selected portfolios: 1) Pre-A investment in Onek Drug (Pharmaceutical distribution B2B platform); 2) Angel investment in AliveX Biotech (AI + immunity platform) - Selected portfolio management: Tezign (Digital creative content solutions for enterprises), Points Technology (Privacy computing), Flexport (The OS of global logistics)
Research Analyst
2017 - 2018
- Performed comprehensive research utilizing both top-down and bottom-up approaches to inform global TMT investment decisions and strategy - Facilitated the establishment of China-US Industrial Cooperation Partnership Fund between CIC and Goldman Sachs PIA
Research Analyst
2014 - 2017
TMT: Technology Hardware TMT Sector Research: Technology Equipment and Hardware; Electronic Component in both A share and H share markets
Summer Research Associate, Equity Research
2013 - 2013
China Bank Research
UBS Realty Investors is an institutional investment advisor that managed real estate equity assets on behalf of its clients.
Summer Intern, Public Equity Investment
2012 - 2012
Summer Resesrch Associate, Equity Research
2012 - 2012
Transportation Sector in A and H-share market